Chicago, ILLINOIS2 Active Studies

Dravet Syndrome Clinical Trials in Chicago, ILLINOIS

Find 2 actively recruiting dravet syndrome clinical trials in Chicago, ILLINOIS. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
172
Enrolling

Recruiting Dravet Syndrome Studies in Chicago

About Dravet Syndrome Clinical Trials in Chicago

Dravet syndrome is a rare, severe form of epilepsy that begins in the first year of life with prolonged seizures often triggered by fever. It is usually caused by mutations in the SCN1A gene. Treatment includes specific antiseizure medications, avoiding certain drugs that can worsen seizures, and investigational gene therapies.

There are currently 2 dravet syndrome clinical trials recruiting participants in Chicago, ILLINOIS. These studies are seeking a combined 172 participants. Research is being sponsored by Epygenix, Encoded Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.

Dravet Syndrome Clinical Trials in Chicago — FAQ

Are there dravet syndrome clinical trials in Chicago?

Yes, there are 2 dravet syndrome clinical trials currently recruiting in Chicago, ILLINOIS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What dravet syndrome treatments are being tested?

The 2 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for dravet syndrome.

Data updated March 2, 2026 from ClinicalTrials.gov